BigHat Biosciences

Dorian Therapeutics, Inc. is a biotechnology company located in San Carlos, California, focused on advancing scientific research and innovation. The company is committed to addressing significant challenges in the field through its dedicated team of scientists and advisors. With a strong emphasis on collaboration, Dorian Therapeutics engages with various communities to foster knowledge sharing and development. Their mission is to contribute to the scientific landscape by exploring novel therapeutic approaches and solutions. Generated from the website

Hoffmann-La Roche, also known as Roche, is prescription drug unit that provides more than 35 medications in the United States in therapeutic areas, including dermatology, oncology, transplantation, AIDS, central nervous system disorders, and cardiovascular and infectious diseases. It offers products that include Accutane, Boniva, CellCept, Copegus, Cytovene, Demadex EC-Naprosyn, Romazicon, Tamiflu, Ticlid, Valcyte, Valium, Xeloda, Xenical and Zenapax. The company operates over five research centers in New Jersey and California in the United States, as well as Switzerland, Germany and China. Hoffmann-La Roche works with a team of nearly 5,000 employees. It is a part of Roche Group, which is one of the world's leading research-oriented health care groups with core businesses in pharmaceuticals and diagnostics. Operational for more than 100 years, the parent company develops a range of products and services that address prevention, diagnosis and treatment of diseases.

Augmenta Bioworks, located in Menlo Park, CA, is dedicated to building global immunity to disease by discovering new therapeutics that harness the power of natural human immunity. Their technology identifies specific immune responses and translates these findings into therapies that can benefit the broader population. Utilizing advanced methods such as automation, microfluidics, high-throughput DNA sequencing, and scalable computational analysis, Augmenta facilitates the discovery of immune receptors and their antigen specificity. Collaborating with pharmaceutical and biotechnology companies, as well as research institutions, they aim to revolutionize approaches to vaccine development, immune engineering, antibody discovery, and cell therapy. Generated from the website